OXYS ~ OxySure Systems, Inc. (OTCQB: OXYS, “OxyS
Post# of 115
markets the OxySure Model 615, a portable emergency oxygen system that has been approved by the FDA for sale over the counter without a prescription.OxySure has been accelerating its penetration in the marketplace, reporting fourteen consecutive quarters of top line growth, including record revenues in 3Q15. We see several catalysts ahead for the company as it heads in to 2016E seeking to uplist to a national exchange and aspiring to reach $10mn in annualized sales and
cash flow break even.
http://www.oxysure.com/OXYS%20Update.%20FINAL%2011-25-15.pdf